Clicky

Guerbet S. A.(GBT)

Description: Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution; Dotarem, a gadoteric acid-gadoterate meglumine, and Artirem, a gadoteric acid that acts as a contrast agent for MRI, as well as prefilled syringes, injectors, accessories, and consumables for MRI, CT, and Cath Lab. It also provides digital solutions, such as Contrast&Care, an injection management solution; Dose&Care, an X-ray dose management solution; and icobrain, a cloud-based AI solution to quantify disease-specific brain structures for acute and chronic neurological conditions on MR and CT, as well as OptiProtect services. In addition, the company provides products for interventional radiology, including Lipiodol ethyl esters of iodinated fatty acids of poppyseed oil; Vectorio, a mixing and injection system for conventional trans-arterial chemoembolization; Patent Blue V, a blue dye; Axessio, a peripheral micro guidewire; and SeQure and DraKon, which are microcatheters. Further, it offers Hydra Vision, a digital imaging system for urological, gastroenterological, and gynecological treatment, as well as planning and diagnostic procedures; and urology accessories and consumables. The company was founded in 1926 and is headquartered in Villepinte, France.


Keywords: Chemical Substances Artificial Intelligence X Ray Diagnostic Imaging MRI Magnetic Resonance Imaging Interventional Radiology Aromatic Compounds Digital Imaging System Radiocontrast Agents

Home Page: www.guerbet.com

15, rue des Vanesses
Villepinte, 93420
France
Phone: 33 1 45 91 50 00


Officers

Name Title
Mr. David Hale CEO, MD & GM
Mr. Philippe Bourrinet Sr. VP of Devel., Medical & Regulatory Affairs
Mr. Jerome Estampes CFO and Sr. VP of Bus. Devel. & Licensing
Ms. Sarah Dayre Sr. VP of Technical Operations
Ms. Charlotte Bamiere Gen. Counsel
Ms. Anne-Laure Delasalle VP of Communications & Image and Director of Communications
Ms. Petra Zalabak Sr. VP of HR & Corp. Social Responsibility
Mr. Jean-Francois Blanc Sr. VP of Interventional Imaging
Mr. Francois Nicolas Sr. VP of R&D, R&I and Chief Digital Officer
Ms. Valérie Brissart Sr. VP of Diagnostic Imaging

Exchange: PA

Country: FR

Currency: Euro (€)

Forward PE: 0
Trailing PE: 17.3131
Price-to-Book MRQ: 0.4747
Price-to-Sales TTM: 0.2664
IPO Date:
Fiscal Year End: December
Full Time Employees: 2730
Back to stocks